OHB’s €240 Close Puts the Stock at a Crossroads Between Technical Support and Capital-Raise Hangover

OHB's €484M capital raise leaves investors with 20% paper losses as stock nears critical 200-day moving average amid weak rights uptake and KKR partial exit.

The arithmetic of OHB’s recent capital increase is brutal in its simplicity: investors who bought at the €300 placement price in early July are already nursing a 20% paper loss, with the stock closing Friday at €240.00. That single figure — a full €60 below the issue price — captures the tension between a company that just raised €484 million in gross proceeds and a market that has repriced the equity far more aggressively than the 8.86% dilution alone would justify.

What makes the current level particularly charged is its proximity to a technical landmark. Friday’s close sits just 0.31% below the 200-day moving average of €240.76, a threshold that technical analysts now regard as the single most important support line for the stock. The relative strength index, at 33.4, already signals oversold conditions, raising the possibility of a bounce — but only if the 200-day line holds.

A Capital Raise That Rewrote the Shareholder Base

The mechanics of the July transaction explain much of the price pressure. OHB completed a two-tranche capital increase that placed 1.605 million new shares alongside 1.395 million existing shares held by KKR-linked Orchid Lux HoldCo. The institutional placement in the first tranche went smoothly, but the second-trance rights offering told a different story: existing minority shareholders subscribed for just 7,635 new shares, leaving the vast majority of the offer unclaimed. That tepid response suggests the market viewed the €300 price as too rich even before the stock began its slide.

The capital injection also reshaped the ownership structure in ways that matter for trading dynamics. Free float rose from 5.7% to as much as 19.2%, potentially improving liquidity over time. But the bulk of the proceeds — roughly €368 million — went to KKR rather than into OHB’s treasury, a partial exit by a major investor that markets often interpret as a signal about valuation. The Fuchs family, which retains more than 60% of the shares, sold no stock in the transaction.

Lock-up agreements add another layer of uncertainty. OHB SE is bound for 180 days, while Orchid Lux HoldCo and Martello Value face 90-day restrictions. FFS GmbH, VOLPAIA Beteiligungs-GmbH, and the management board committed for twelve months. When the shortest of these periods expires, additional supply could test the fragile floor.

Political Tailwinds Meet Market Indifference

The disconnect between OHB’s operational trajectory and its stock price has rarely been starker. On July 14, German Defense Minister Boris Pistorius visited OHB’s Bremen facility to discuss satellite reconnaissance and launch capabilities with CEO Marco Fuchs. Ten days later, OHB and the European Spaceport Company publicly backed Pistorius’s initiative to explore a military launch site for carrier rockets, framing it as a matter of national sovereignty in space. On July 21, OHB System issued an advance work authorization to MDA Space UK for landing sensors on the European Space Agency’s Argonaut lunar mission.

Three strategic milestones in as many weeks — a defense minister’s visit, a sovereignty debate, and a moon mission contract — paint a picture of a company at the center of Europe’s push for independent space access. The stock has ignored the narrative entirely, following instead the mechanical logic of the capital raise and the withdrawal of price support.

That support ended on July 24, when J.P. Morgan SE concluded its stabilization period for the new shares. Since June 24, the bank had acted as stabilization coordinator, providing technical underpinning for the stock. With that prop removed, OHB faces its first unassisted trading session — a test that the 200-day moving average will measure in real time.

What the Charts Say About the Next Move

The 30-day decline of 34.6% has pushed the stock 65.12% below its spring record high, a correction that automated models classify as oversold. Whether that signals a bottom or a pause before further weakness depends entirely on the 200-day line. If the stock defends the €240.76 zone, the oversold RSI reading supports the case for stabilization after the recent rout. If it breaks decisively below, the next identifiable support sits at the 52-week low of €64.00 — a level that, given the stock’s year-to-date gains, remains an unlikely but technically plausible destination.

The annualized 30-day volatility of over 80% underscores that swings in either direction remain possible at any moment.

The Earnings Test Ahead

The next concrete catalyst arrives on August 6, when OHB reports second-quarter results. That report will offer the first operational evidence of whether the €484 million capital injection and the political backing from Berlin are translating into financial performance. The company has signaled plans to use the funds for production industrialization, potential acquisitions, and rocket projects — investments that could strengthen the fundamental case once the selling pressure from the capital raise subsides.

The third-quarter report, due later in the year, will provide an update on whether OHB is already deploying capital for acquisitions in the consolidating European space market. For now, the stock is trading on technicals and capital structure mechanics, not on the strategic narrative that management and politicians are advancing. The 200-day moving average will determine which story wins in the near term.